PR/SET Domain Family and Cancer: Novel Insights from The Cancer Genome Atlas

The PR/SET domain gene family (PRDM) encodes 19 different transcription factors that share a subtype of the SET domain [Su(var)3-9, enhancer-of-zeste and trithorax] known as the PRDF1-RIZ (PR) homology domain. This domain, with its potential methyltransferase activity, is followed by a variable number of zinc-finger motifs, which likely mediate protein–protein, protein–RNA, or protein–DNA interactions. Intriguingly, almost all PRDM family members express different isoforms, which likely play opposite roles in oncogenesis. Remarkably, several studies have described alterations in most of the family members in malignancies. Here, to obtain a pan-cancer overview of the genomic and transcriptomic alterations of PRDM genes, we reanalyzed the Exome- and RNA-Seq public datasets available at The Cancer Genome Atlas portal. Overall, PRDM2, PRDM3/MECOM, PRDM9, PRDM16 and ZFPM2/FOG2 were the most mutated genes with pan-cancer frequencies of protein-affecting mutations higher than 1%. Moreover, we observed heterogeneity in the mutation frequencies of these genes across tumors, with cancer types also reaching a value of about 20% of mutated samples for a specific PRDM gene. Of note, ZFPM1/FOG1 mutations occurred in 50% of adrenocortical carcinoma patients and were localized in a hotspot region. These findings, together with OncodriveCLUST results, suggest it could be putatively considered a cancer driver gene in this malignancy. Finally, transcriptome analysis from RNA-Seq data of paired samples revealed that transcription of PRDMs was significantly altered in several tumors. Specifically, PRDM12 and PRDM13 were largely overexpressed in many cancers whereas PRDM16 and ZFPM2/FOG2 were often downregulated. Some of these findings were also confirmed by real-time-PCR on primary tumors.

[1]  M. Alcalay,et al.  The Tumor Suppressor PRDM5 Regulates Wnt Signaling at Early Stages of Zebrafish Development , 2009, PloS one.

[2]  S. Orkin,et al.  FOG, a Multitype Zinc Finger Protein, Acts as a Cofactor for Transcription Factor GATA-1 in Erythroid and Megakaryocytic Differentiation , 1997, Cell.

[3]  Ying Xim Tan,et al.  The role of PRDMs in cancer: one family, two sides. , 2016, Current opinion in genetics & development.

[4]  Yang Zhang,et al.  The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.

[5]  C. Napoli,et al.  Identification of valid reference housekeeping genes for gene expression analysis in tumor neovascularization studies , 2013, Clinical and Translational Oncology.

[6]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[7]  A. Godzik,et al.  Comparison of algorithms for the detection of cancer drivers at subgene resolution , 2017, Nature Methods.

[8]  F. Ciccarelli,et al.  Family expansion and gene rearrangements contributed to the functional specialization of PRDM genes in vertebrates , 2007, BMC Evolutionary Biology.

[9]  E. Lander,et al.  Lessons from the Cancer Genome , 2013, Cell.

[10]  Jun Yu,et al.  The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/β-Catenin Signaling and Is Frequently Silenced in Multiple Tumors , 2011, PloS one.

[11]  F. Cole,et al.  Missing the Mark: PRDM9-Dependent Methylation Is Required for Meiotic DSB Targeting. , 2018, Molecular cell.

[12]  Lei Jiang,et al.  RIZ1: a potential tumor suppressor in glioma , 2015, BMC Cancer.

[13]  A. Ciccodicola,et al.  Human PRDM2: Structure, function and pathophysiology. , 2018, Biochimica et biophysica acta. Gene regulatory mechanisms.

[14]  Valerio Costa,et al.  Pan-Cancer Mutational and Transcriptional Analysis of the Integrator Complex , 2017, International journal of molecular sciences.

[15]  L. Duret,et al.  PRDM9 Methyltransferase Activity Is Essential for Meiotic DNA Double-Strand Break Formation at Its Binding Sites. , 2018, Molecular cell.

[16]  A Mayakonda,et al.  Maftools: Efficient analysis, visualization and summarization of MAF files from large-scale cohort based cancer studies , 2016, bioRxiv.

[17]  G. Shao,et al.  The PR Domain of the Rb-binding Zinc Finger Protein RIZ1 Is a Protein Binding Interface and Is Related to the SET Domain Functioning in Chromatin-mediated Gene Expression* , 1998, The Journal of Biological Chemistry.

[18]  Peng-Fei Xu,et al.  Genome-Wide Survey and Developmental Expression Mapping of Zebrafish SET Domain-Containing Genes , 2008, PloS one.

[19]  Gad Getz,et al.  Analysis of somatic microsatellite indels identifies driver events in human tumors , 2017, Nature Biotechnology.

[20]  Yang Zhang,et al.  I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.

[21]  N. Yoo,et al.  Intratumoral Heterogeneity of Frameshift Mutations in MECOM Gene is Frequent in Colorectal Cancers with High Microsatellite Instability , 2016, Pathology & Oncology Research.

[22]  K. Quinlan,et al.  The Identification and Structure of an N-Terminal PR Domain Show that FOG1 Is a Member of the PRDM Family of Proteins , 2014, PloS one.

[23]  K. Kinzler,et al.  Evaluating the evaluation of cancer driver genes , 2016, Proceedings of the National Academy of Sciences.

[24]  Vivien Marx,et al.  Cancer genomes: discerning drivers from passengers , 2014, Nature Methods.

[25]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[26]  Pierre Kerner,et al.  Evolution of Prdm Genes in Animals: Insights from Comparative Genomics , 2015, Molecular biology and evolution.

[27]  Tobias Hohenauer,et al.  The Prdm family: expanding roles in stem cells and development , 2012, Development.

[28]  Steven P. Gygi,et al.  Initiation of myoblast/brown fat switch through a PRDM16-C/EBP-β transcriptional complex , 2009, Nature.

[29]  Yang Zhang,et al.  I-TASSER server for protein 3D structure prediction , 2008, BMC Bioinformatics.

[30]  M. Kadota,et al.  PRDM14 Drives OCT3/4 Recruitment via Active Demethylation in the Transition from Primed to Naive Pluripotency , 2016, Stem cell reports.

[31]  Guido Marcucci,et al.  CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice. , 2016, Blood.

[32]  David Tamborero,et al.  OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..

[33]  C. Abbondanza,et al.  PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation , 2013, Biology.

[34]  Roded Sharan,et al.  Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer , 2015, PLoS Comput. Biol..

[35]  G. G. Galli,et al.  PRDM proteins: important players in differentiation and disease. , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[36]  P. Cohen,et al.  The Multifaceted Roles of PRDM16: Adipose Biology and Beyond , 2016, Trends in Endocrinology & Metabolism.

[37]  Tae Hoon Kim,et al.  PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. , 1999, Genes & development.

[38]  Lana X. Garmire,et al.  More Is Better: Recent Progress in Multi-Omics Data Integration Methods , 2017, Front. Genet..

[39]  M. Sung,et al.  A Macrohistone Variant Links Dynamic Chromatin Compaction to BRCA1-Dependent Genome Maintenance , 2014, Cell reports.

[40]  B. Spiegelman,et al.  PRDM16 controls a brown fat/skeletal muscle switch , 2008, Nature.

[41]  I. Tomlinson,et al.  The mini-driver model of polygenic cancer evolution , 2015, Nature Reviews Cancer.